Brief: Isofol Medical Completes Phase 1/2a Study ISO-CC-005
Jan 30 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* THE PHASE 1/2A STUDY ISO-CC-005 IS COMPLETED
* ISOFOL MEDICAL AB (PUBL) - FINAL ANALYSIS HAS STARTED AND
STUDY
DATA IS EXPECTED TO BE PRESENTED AT ESMO 2020.
* ISOFOL MEDICAL AB (PUBL) - TOTALLY 101 PATIENTS HAVE BEEN
TREATED AT 10 HOSPITALS IN NORDIC COUNTRIES AND EUROPE
Source text for Eikon: ID:nWkr8CkXg7
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical reports no Q2 revenue, net loss widens
Brief: Isofol Medical Q2 Net Income SEK -15.729 Million
Brief: Isofol Medical Adds Clinical Trial Sites To Phase Ib/Ii Arfolitixorin Study In Colorectal Cancer
Sweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million